Stocks to watch next week: Broadcom, Lululemon, British American Tobacco, Dr Martens and Rémy Cointreau
Tariffs remain in focus as earnings season continues to wind down, but there are still a number of key companies due to report in the coming week.
On the back of a strong set of results from chipmaking giant Nvidia (NVDA), attention will now turn to rival Broadcom (AVGO), which is due to report on Thursday.
Athletics wear company Lululemon (LULU) is also due to report on Thursday, with focus on its outlook for the current year, after guidance offered at the end of the last financial year failed to impress investors.
In London, investors will want to see if British American Tobacco (BATS.L) has continued to generate sales growth from its new categories business, which includes vapes and heated products.
Investors will also be keen to see how Dr Martens (DOCS.L) turnaround efforts are progressing when the iconic bootmaker reports its full-year results on Thursday.
On the Paris bourse, Rémy Cointreau's (RCO.PA) full-year performance will be in focus, ahead of a new CEO taking the helm at the French spirits company later in June.
Here's more on what to look out for:
Shares in Nvidia (NVDA) jumped after it reported another blowout quarter on Wednesday, despite the company warning of the impact of export controls that limit its ability to ship products to China.
The chipmaker posted revenue of $44.1bn (£32.7bn) for the first quarter, beating expectations of $43.3bn, though earnings per share of $0.81 came in below estimates of $0.93.
Derren Nathan, head of equity analysis at Hargreaves Lansdown, said: "The first key takeaway from Nvidia's (NVDA) Q1 print was that demand for accelerated computing remains extremely strong due to the lightning speed roll out of AI. The second is that Nvidia remains the dominant force in this market."
"However, with McKinsey predicting a spend of around $7tn to help data centres keep pace with processing demands out to 2030, the market is big enough to accommodate more than just one player," he added. "Broadcom's (AVGO) custom ASIC chips can help hyperscalers lower their average cost of data processing and as such it looks well set to grow its share of the market."
Read more: What's behind the surge in AI-related lawsuits?
Nathan said that consensus forecasts for Broadcom's (AVGO) second quarter revenue are broadly in line with the company's guidance of approximately $14.9bn, which works out to growth of around 19%.
He highlighted that artificial intelligence (AI) is a "growing share of Broadcom's (AVGO) revenue base but there's still more sales coming from non-AI workloads leaving the company exposed to cyclical ups and downs, which is a risk in today's macroeconomic environment. And with 20% of revenue coming from China, markets will be keen to hear the potential impact of export restrictions and tariffs."
Nathan added that estimates for Broadcom's (AVGO) third quarter revenue have been falling slightly over the last month and currently stand at $15.8bn. "But with so many moving parts to the picture the company's steer will be a key metric to focus on," he said.
Broadcom (AVGO) shares popped after the company posted first quarter results in March that beat on the top and bottom lines, driven by AI chip sales. Adjusted net revenue came in at $14.92bn, versus expectations of $14.61bn, while adjusted earnings per share of $1.60 were ahead of estimates of $1.50. However, fluctuations in the stock since then have left it up just 4.4% year-to-date.
Shares in Lululemon (LULU) sunk after its earnings outlook appeared to underwhelm investors, despite the company posting better-than-expected quarterly profits in March.
The athletics wear retailer said it expected earnings per share for this year to be in the range of $14.95 to $15.15, which was below expectations of $15.37. On revenue, the company said it expected this to be in the range of $11.15bn to $11.3bn.
In addition, Lululemon (LULU) chief financial officer (CFO) told investors on an earnings call that the company was not expecting store traffic to improve this year versus softness out of the gate in the first quarter.
Read more: Stocks that are trending today
In a note on 12 May, Barclays analysts – which had an "equal weight" rating on Lululemon (LULU) – said they were "cautious" on the stock.
They highlighted that the retailer's "We Made Too Much" online clearance section "showed an increase towards the end of the quarter".
"During 1Q25, the WMTM category negatively inflected in the final few weeks of the quarter," they said.
They said this suggested "potential for weaker exiting trends and building inventory risk".
For the first quarter, Lululemon (LULU) said it expected net revenue to come in between $2.34bn and $2.36bn, which would represent growth of 6% to 7%. Diluted earnings per share are expected to be in the range of $2.53 to $2.58 for the quarter.
On Wednesday, British American Tobacco (BATS.L) announced that it had sold a 2.5% stake in Indian consumer goods company ITC (ITC.NS), which was worth $1.5bn, according to a Reuters report.
The company said that the transaction would give it "greater financial flexibility as it delivers on its commitment to invest behind transformation, deleverage and enhance shareholder returns."
The tobacco giant also said that the net proceeds from the trade would be used to extend its existing share buyback programme by an additional £200m ($269.5m), taking the total amount it repurchases in 2025 to £1.1bn.
That was up on £900m BAT (BATS.L) said it planned to undertake in buybacks this year back in its preliminary results release in February.
Shares tumbled after the release of those results, in which the company flagged £6.2bn ($7.7bn) hit, from a proposed settlement of a long-running lawsuit in Canada. With this provision, the company posted reported profit from operations for the year of £2.74bn.
Read more: Government 'megafund' pension plans could give £6k boost to savers
BAT (BATS.L) posted a 5.2% decline in reported revenue for the year at £25.9bn, driven by the sale of its businesses in Russia and Belarus in September 2023 and transnational foreign exchange headwinds. However, the company saw 8.9% organic growth from revenue in its new categories business at £3.4bn.
Nathan, of Hargreaves Lansdown, said that the company "heads into its upcoming [first-half] trading update with investor attention firmly on its ability to navigate persistent industry headwinds".
"Regulatory pressures and rising tobacco taxes continue to weigh on the outlook," he said.
"As such, this year's guidance for around 1% sales growth and 1.5–2.5% profit growth currently stands below the group's medium-term targets. The upcoming update will be closely watched for signs that 'new categories' can deliver more meaningful growth and help offset the structural decline in traditional tobacco."
In addition, Nathan said that investors "will be watching closely to see if US action to crackdown on illegal competition has had any impact and whether the lifting of a proposed ban on menthol cigarettes has helped the outlook".
According to consensus forecasts provided by the company on its website, analysts expect full-year total revenue for 2025 to come in at £26.2bn, including £3.88bn from new category business.
Shortly after taking over as Dr Martens (DOCS.L) CEO in January, Ije Nwokorie said in a third quarter trading update that the bootmaker had made "good progress" on turning round performance in the US.
He said that the team were focused on "returning the business to sustainable and profitable growth".
In the third quarter, Dr Martens (DOCS.L) reported 3% growth in group revenue at £267m, with a 4% increase in direct-to-consumer business in the Americas.
"Dr Martens (DOCS.L) is expected to deliver more evidence that it is pulling itself up by its bootstraps and the turnaround is lacing together," said Susannah Streeter, head of money and markets at Hargreaves Lansdown. "It's been reducing inventories and debt, preserving cash and stabilising the business overall."
Stocks: Create your watchlist and portfolio
"The iconic footwear company has found it hard going stomping new fashion ground overseas, with the US, its biggest market, proving particularly tough," she said. "But in the key autumn/winter season, there were signs that increased investment in marketing was paying off, with new styles winning fans. It's trying to get the heritage models and new innovations in the fashion market."
Streeter said that the "performance of the last quarter will be a test" for new CEO Nwokorie.
She said that the company's "strategy includes new store roll outs and increasing the direct-to-consumer mix, as well as improving the quality and depth of wholesale distribution.
"It's hoped that the Docs will also take a step forward with the appointment of a new chief brand officer, Carla Murphy, a former Adidas (ADS.DE) global executive who also has experience at VF Corporation, the American global apparel and footwear company."
In its January trading update, company didn't offer specifics on its guidance for the full year but said its outlook remained unchanged and that it was on track to achieve its objectives. Despite signs of turnaround progress, the stock is still down nearly 19% year-to-date.
French cognac maker Rémy Cointreau (RCO.PA) announced on Wednesday that it had appointed Franck Marilly as the company's new CEO, taking over from Eric Vallat, who said last month he would be stepping down.
Marilly, who assumes the role on 25 June, has previously worked for Japanese beauty brand Shiseido (4911.T), luxury fashion house Chanel and consumer goods giant Unilever (ULVR.L).
The news comes as Rémy Cointreau (RCO.PA) navigates challenges around trade tensions with both the US and China, two of its key markets.
In a fourth quarter sales update in April, Rémy Cointreau (RCO.PA) posted an 18% fall in full-year sales at €984.6m (£827.6m). The company flagged a "steep decline" in sales of cognac in China in the fourth quarter, which it said was partly down to "harsh market conditions", among other factors.
Read more: UK 'bargain' stocks that have outperformed the market long-term
In January, China launched an anti-dumping investigation on brandy imported from the European Union (EU), which was extended in April and included the imposing of temporary duties on imports of brandy. The probe was considered to be in response to EU duties on Chinese electric vehicles.
Rémy Cointreau (RCO.PA) said in its April sales update that if the provisional duties were confirmed, the company would "trigger its action plan to mitigate the effects starting in fiscal 2025-26. The impact on fiscal year 2024-25 is marginal."
In addition, there is also uncertainty around US tariffs on the EU, with talks between the two ongoing, after president Donald Trump hit pause on his threat to impose 50% duties on the bloc.
Investors will be looking at Rémy Cointreau's (RCO.PA) final full-year results on Wednesday for any commentary around the potential impact of these tariff challenges in the year ahead.
The company said in April that a €50m (£42m) cost-cutting plan would help protect its operating margin, expecting this to come in between 21% and 22% for the year. It also reiterated its financial targets for 2029-30 of hitting a gross margin of 72% and an operating margin of 33%.
Monday 2 June
Sirius Real Estate (SRE.L)
Campbell's Co (CPB)
Tuesday 3 June
Chemring (CHG.L)
Pennon (PNN.L)
Gooch & Housego (GHH.L)
Crowdstrike Holdings Inc (CRWD)
Ferguson Enterprises Inc (FERG)
Dollar General Corp (DG)
Hewlett Packard Enterprise (HPE)
Nio Inc (NIO)
Signet Jewelers (SIG)
Wednesday 4 June
Paragon Banking (PAG.L)
B&M European Value Retail (BME.L)
DiscoverIE (DSCV.L)
Ramsdens (RFX.L)
Dollar Tree Inc (DLTR)
GameStop (GME)
Thursday 5 June
Mitie (MTO.L)
Workspace (WKP.L)
Young's & Co Brewery (YNGN.L)
Fevertree (FEVR.L)
Fastenal (FAST)
DocuSign (DOCU)
Brown-Forman (BF-B)
Ciena (CIEN)
Wizz Air Holdings (WIZZ.L)
CMC Markets (CMCX.L)
Friday 6 June
ABM Industries Inc (ABM)
Caffyns (CFYN.L)
You can read Yahoo Finance's full calendar here.
Read more:
How getting ahead on your tax return can help cut your tax bill
Odds of more Bank of England interest rate cuts fall as food inflation rises
Trump tariffs to hit UK economy next year, says IMF
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Sanofi (ENXTPA:SAN) Reports Positive Phase 3 Results for Itepekimab in COPD Trial
Sanofi announced that its AERIFY-1 trial with Regeneron Pharmaceuticals successfully met its primary endpoint, indicating progress in COPD treatment. Despite this positive news, the company's share price fell 5% over the last week, contrasting with a 2% rise in the broader market. This decline may reflect investors' reactions to other company initiatives, such as its partnership with Stagecoach Performing Arts to raise awareness of autoimmune Type 1 diabetes. These positive developments, although promising, were not enough to counterbalance the broader market's upward trend, contributing weight against Sanofi's price movement. Buy, Hold or Sell Sanofi? View our complete analysis and fair value estimate and you decide. Uncover the next big thing with financially sound penny stocks that balance risk and reward. The recent successful completion of Sanofi's AERIFY-1 trial could have a positive impact on its revenue and earnings forecasts by strengthening its position in the COPD treatment market. However, despite these promising developments, the company's share price experienced a 5% decline in the past week, contrasting with the broader market's 2% rise. This movement might reflect investor reactions to other company initiatives, such as the partnership with Stagecoach Performing Arts, and broader market trends. Looking at a longer-term context, Sanofi's shares have delivered a total return of 19.59% over the past five years. Recent performance has exceeded the French Pharmaceuticals industry and market, which returned 4% and 4.5% declines respectively over the last year. Such outperformance indicates resilience amidst industry challenges and market volatility. Please consider the current share price of €95.9 against the consensus price target of €117.17, indicating a potential upside potential of approximately 18.5%. This price target is based on expectations of revenue reaching €51.2 billion and earnings of €10.2 billion by 2028, trading on a PE ratio of 16.1x. Analysts are assuming that Sanofi will enhance its growth trajectory driven by its innovative treatments and efficient operational strategies. Assess Sanofi's previous results with our detailed historical performance reports. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ENXTPA:SAN. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
The Drive
an hour ago
- The Drive
Vespa's 1950s Microcar Was Just As Cute as Its Scooters
Get The Drive's daily newsletter The latest car news, reviews, and features. Email address Sign Up Thank you! Terms of Service & Privacy Policy. Let's face it: cute is gonna cute. I mean, a mini Mini is a thing, so, of course, a cuter Vespa would exist. And this time, no chop shops are involved. In fact, this adorbs Vespa has four wheels and is French. According to Below the Radar, the manufacturer now known for scooters also built a teeny transporter from 1957 to 1961. With a 393cc two-stroke two-cylinder engine mounted in the rear, the Vespa 400 was smaller than its counterparts from Fiat and Mini. Measuring just 113 inches in length, the Vespa 400 was five inches shorter than the Fiat 500, which debuted the same year, and took up eight fewer inches than the incoming Mini Cooper that would launch in 1959. Other specs include 14 horsepower and a top speed of about 50 mph. Equipped with a three-speed manual, zero to 40 mph took a leisurely 23 seconds. Utilizing less than 9.5 feet of street space, understandably, there was only room for two occupants. Despite the rear engine, the Vespa 400 had no frunk. That space was actually where your feet would go. Vespa left no space to waste in its already tight-quartered 400. Ingress and egress were made easy via rear-hinged doors. Have luggage? There was a small area behind the two seats for that purpose. Have a kid? A small cushion could be fitted in between the seats to create a temporary bench. Have more than one kid? Hmm, how do I put this? You purchased the wrong vehicle. As the story goes, the Vespa 400 was manufactured out of a factory in Fourchambault, France, to take advantage of the market's growing affinity for microcars. Or perhaps because Fiat was going to have a fit and launch a competing cutesy scooter. Italian tit for tats aside, the Vespa 400 sold well during its first run out the gate with more than 12,000 sold, but sales slid in the following years. Mostly left-hand drive, the Vespa microcar was sold throughout Europe, with about 1,700 actually finding their way stateside. When the Vespa 400 was finally imported to the UK, a vehicle review at the time offered positive remarks. 'Helped by the well-sprung seats, ride comfort is unusually good for such a small car…There is little to distinguish the Vespa from a normal family car, apart from its size,' wrote The Motor, as shared by Below the Radar. That 1959 Vespa 400 cost 351,725 French francs or 255 British pounds. Bring a Trailer Unfortunately, not many have survived, but shiny side up examples can be found, like this one listed on Bring a Trailer which put the car back on our radar today. This little red number with a matching red and tan patterned interior has been an Arizona resident since the late 1960s and underwent a refurbishment in 2015. The speedometer has been replaced, so its true mileage is unknown, but it's a fact that the Vespa 400 is super cute with those 10-inch polished steelies. Offered at no reserve. The vehicle was purchased less than a year ago, selling for $21,023. However, with only a day to go, the current high bid is just $9,000. Are there any other tiny cars from scooter brands we should know about? Drop us a line at tips@
Forbes
an hour ago
- Forbes
CEOs Jensen Huang And Dario Amodei On AI: Adapt Or Be Replaced
Jensen Huang and Dario Amodei's warning about AI. AFP via Getty Images One predicts AI will put 40 million people back to work. The other warns it could drive mass unemployment. Nvidia's Jensen Huang and Anthropic's Dario Amodei, despite their contrasting tones, are both broadcasting the same underlying truth: evolve or risk becoming obsolete. Whether it's reshaping industries, redefining roles, or redrawing the line between relevance and redundancy, AI is here in full force. For leaders, the question isn't whether AI will change everything. It's whether you're willing to change yourself fast enough to stay afloat. This realization of AI is what makes Huang's and Amodei's recent comments so critical. Not because they agree on the outcomes but because they're waving the same flag: radical adaptability isn't optional anymore. At the recent Milken Conference, Nvidia's Jensen Huang didn't sugarcoat the potential impact of AI. "Every job will be affected, and immediately," he warned. But Huang wasn't forecasting dystopia; he was emphasizing opportunity. In his view, AI can close global talent gaps, increase the GDP, and level the playing field. However, this only happens if people commit to learning and fully embracing artificial intelligence. "You're not going to lose your job to AI," he said. "You're going to lose your job to someone who uses AI." Anthropic CEO Dario Amodei, by contrast, is raising the alarm. In recent interviews, he has been straightforward: AI is improving at nearly all intellectual tasks, even those typically performed by CEOs. In a discussion with Axios, he predicted that up to 50% of entry-level white-collar jobs could vanish within five years. He put it this way: 'Cancer is cured, the economy grows at 10% a year, the budget is balanced—and 20% of people don't have jobs.' These aren't opposing views. They're parallel warnings. Both point to the same truth: the cost of ignoring AI is compounding, particularly for those in leadership positions. No matter which prediction you believe, the path forward is the same. Radical adaptability is no longer a nice to have. It's the currency of continued relevance that gives you the best chance of staying ahead. It's about rewiring how you lead, think, and operate at the speed of disruption. In this new reality, clinging to stability is akin to a slow-motion decline. Here are two principles to begin practicing radical adaptability: Intel founder Andy Grove once wrote, "Only the paranoid survive." That mindset isn't about fear—it's about foresightedness. Huang echoes this sentiment: no role is immune from AI's reach, and machines won't overtake those who delay adapting—they'll be outpaced by those who have already learned to use them. Amodei also points to this blind spot, warning that most people—and many leaders—still don't realize how fast things are moving. That kind of lag in awareness is where disruption thrives. Practicing healthy paranoia means scanning for cracks before they break open. It's asking difficult questions before the market forces you to. It's not just designing a strategy for what could succeed—but instead for what could make today's model obsolete. Build before it's obvious. In the age of AI, staying a little paranoid might be your strongest competitive edge. According to the 2025 World Economic Forum's "Future of Jobs" Report, 41% of companies plan to downsize due to the impact of AI; however, 77% plan to reskill or upskill their employees. It's never been more obvious: what got you here won't keep you here. Amodei's warning about AI's acceleration on intellectual tasks shows that static expertise now has a short shelf life. Leaders who thrive will treat reinvention not as a pivot—but as a permanent operating system. That means evolving your digital fluency and skills, rethinking communication styles, and being willing to redefine what leadership looks like in a more machine-augmented world. Whether AI becomes a net benefit or net threat will be debated for years. But as both Huang and Amodei stress, this isn't something you can ignore. And for those in leadership, AI won't just test your strategy. It will test your identity. This scenario is where your ego comes into play. Leaders who are rigid in how they see themselves, their roles, or their industry will fall behind. The future won't belong to the biggest or the smartest. It'll belong to the most adaptable.
